title: [Suspension of Diane35 and its generics: an over-reaction by the French National Medicines Agency (ANSM) unfounded in the light of proven or accepted medical knowledge].
authors.forename: J-M
authors.initials: JM
authors.lastname: Debarre
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy; D000726:Androgen Antagonists / Q000009:adverse effects / Q000627:therapeutic use; D003277:Contraceptives, Oral, Combined / Q000009:adverse effects; D003278:Contraceptives, Oral, Hormonal / Q000009:adverse effects; D017373:Cyproterone Acetate / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D004363:Drug Utilization / Q000706:statistics & numerical data; D016568:Drugs, Generic; D004997:Ethinyl Estradiol / Q000009:adverse effects / Q000627:therapeutic use; D019317:Evidence-Based Medicine; D005260:Female; D005602:France; D006077:Government Agencies; D006801:Humans; D018570:Risk Assessment; D056737:Safety-Based Drug Withdrawals / Q000331:legislation & jurisprudence*; D020246:Venous Thrombosis / Q000139:chemically induced / Q000401:mortality
chemical_list: D000726:Androgen Antagonists; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D004338:Drug Combinations; D016568:Drugs, Generic; D004997:Ethinyl Estradiol; D017373:Cyproterone Acetate; C032640:Cyproterone acetate, ethinyl estradiol drug combination